Pyxis Oncology

PYXSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$236.316 M

$3.73 -0.53%

Close of 7 Aug 2026

Revenue

$13.9M

#3100 by revenue

Earnings

-$79.6M

Loss-making

Shares outstanding

62,831,246

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#257OrganogenesisORGO$239.3M
#258Capricor TherapeuticsCAPR$236.9M
#259Pyxis OncologyPYXS$236.3M
#260Keros TherapeuticsKROS$221.1M
#261Siga TechnologiesSIGA$218.8M

Where these numbers come from

Share counts and financials for Pyxis Oncology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.